Considering that KRAS mutation might occur as an early event in pancreatic adenocarcinoma, the present study began with KRAS mutation grouping, which was followed by the construction of prognostic models based on WGCNA to predict the prognosis of PAAD. The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.